معرفی
Dr Simone Visser is a Lecturer in Pharmacology at the University of Sydney's Faculty of Medicine and Health. Her research focuses on respiratory diseases, particularly cystic fibrosis, interstitial lung disease, and bronchiectasis. She explores clinical management strategies, molecular mechanisms of genetic mutations (e.g., CFTR proteins), and the efficacy of therapies like CFTR modulators. Her work also addresses healthcare optimization, including telemedicine applications and cost-efficiency in multidisciplinary virtual clinics.
Her research interests span pharmacology, respiratory medicine, and genetic disorders, with a strong emphasis on translating molecular insights into clinical practice. Recent studies highlight non-invasive ventilation outcomes, exercise-induced oxygen desaturation screening, and the impact of drug combinations on biofilms in cystic fibrosis pathogens.
Collaborations include projects on home spirometry performance, registry comparisons for bronchiectasis epidemiology, and risk-benefit analyses of treatments for cystic fibrosis liver disease. While no scientific awards are listed, her contributions to cystic fibrosis care and pharmacological research are evident through her publication record.
Dr Visser's work integrates clinical data with molecular pharmacology, aiming to improve treatment protocols and patient outcomes in chronic respiratory conditions. She actively participates in interdisciplinary teams, including studies led by colleagues like Professors Bell, Bye, and Morgan, but specific grant details or lab affiliations are not provided in the text.
